During the past decade, Florida Retina Institute conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 7 clinical trials were completed. i.e. 70% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Retina Institute" #1 sponsor was "Jaeb Center for Health Research" with 15 trials, followed by "Kodiak Sciences Inc" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Aldeyra Therapeutics, Inc." with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Retina Institute" #1 collaborator was "National Eye Institute (NEI)" with 13 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Allergan" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 3 trials as a collaborator and "Regeneron Pharmaceuticals" with 3 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Florida Retina Institute" are "Diabetic Macular Edema" (13 trials), "Diabetic Retinopathy" (8 trials), "Macular Edema" (2 trials), "Neovascular Age-Related Macular Degeneration" (2 trials) and "Proliferative Diabetic Retinopathy" (2 trials). Many other conditions were trialed in "Florida Retina Institute" in a lesser frequency.

Most popular intervention types in "Florida Retina Institute" are "Drug" (23 trials), "Other" (8 trials), "Procedure" (6 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (3 trials), "KSI-301" (3 trials), "Sham Procedure" (3 trials), "Sham injection" (3 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Florida Retina Institute" are 27 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Florida Retina Institute". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Florida Retina Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Retina Institute, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".